TruVision®
Search documents
Odysight.ai Reports Financial Results for The Nine Months Ended September 30, 2025 and Provides Business Update
Globenewswire· 2025-11-13 13:10
Core Insights - Odysight.ai Inc. has reported financial results for the nine months ending September 30, 2025, indicating a transformative phase with a focus on growth and market adoption of its visual sensing and AI analytics technologies [1][3]. Financial Performance - Revenues for the first nine months of 2025 were approximately $2.6 million, a slight decrease from $2.7 million in the same period of 2024 [7][8]. - The cash balance as of September 30, 2025, was approximately $29.8 million, significantly up from $13.6 million a year earlier [12]. - The backlog stood at approximately $14.2 million as of September 30, 2025, with monetization expected to continue through 2026 and beyond [2][9]. Business Developments - The company has successfully transitioned from the medical device market to aerospace, transportation, and industrial sectors, with commercial aerospace revenues booked in 2025 [4]. - Key achievements include the first operational footprint in Europe with the Italian Air Force and the delivery of a vision-based monitoring system for the Heron TP UAV [4]. - Odysight.ai has signed a strategic partnership to integrate its predictive health monitoring system across various sectors, including defense and heavy vehicles [4]. Operational Highlights - The gross profit for the nine months ended September 30, 2025, was $0.7 million, reflecting a gross margin of approximately 27%, compared to a gross margin of 26% in the previous year [10]. - Operating expenses increased to $14.4 million, up from $9.4 million in the same period of 2024, primarily due to expansion efforts and marketing activities [11]. - The net loss for the nine months was $12.8 million, compared to a net loss of $8.2 million in the prior year [12].